China Pediatric Pharmaceuticals, Inc. Reports Reverse Merger, 2009 Results

ChinaBio Today -- China Pediatric Pharmaceuticals, Inc., which completed its reverse merger in October 2009, said its revenues rose 14% in 2009 to $16.7 million, though net income declined slightly to $2.5 million. The company ended its fiscal year with $900,000 in cash. Its only operating entity is Shaanxi Jiali Pharmaceutical Co., Ltd., headquartered in Xi’an. More details...

MORE ON THIS TOPIC